Opinion - (2025) Volume 8, Issue 5
Received: 01-Oct-2025, Manuscript No. japre-26-182001;
Editor assigned: 03-Oct-2025, Pre QC No. P-182001;
Reviewed: 17-Oct-2025, QC No. Q-182001;
Revised: 22-Oct-2025, Manuscript No. R-182001;
Published:
29-Oct-2025
, DOI: 10.37421/2684-5997.2025.8.312
Citation: Mansour, Khaled A.. ”Cancer Pain Management: A Multidisciplinary Approach.” J Anesthesiol Pain Res 08 (2025):312.
Copyright: © 2025 Mansour A. Khaled This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The management of cancer-related pain is a complex and multifaceted challenge that requires a comprehensive and individualized approach. Anesthesiologists play a pivotal role in this process, utilizing a wide array of pharmacologic and interventional strategies to alleviate suffering and improve the quality of life for patients battling cancer. This introductory section will explore the foundational principles and diverse modalities employed in modern cancer pain management, drawing upon the insights from various leading publications in the field. We begin by acknowledging the critical role of anesthesiologists in managing cancer-related pain, emphasizing the multidisciplinary approach, pharmacologic strategies, and interventional techniques, alongside the psychological and existential aspects of pain and the importance of early intervention to enhance quality of life [1].
The optimal use of opioids is central to effective cancer pain management, with a focus on balancing efficacy, managing side effects, and mitigating the risk of addiction. Current guidelines for opioid rotation, dose escalation, and the management of common opioid-induced adverse events, such as constipation and nausea, are crucial for maximizing therapeutic benefit while minimizing harm. Challenges associated with breakthrough pain also necessitate careful consideration and tailored strategies [2].
For patients whose pain is refractory to conventional pharmacologic treatments, interventional pain management techniques offer significant relief. These advanced procedures, including epidural and intrathecal drug delivery, celiac plexus blocks, and superior hypogastric plexus blocks, are detailed along with their specific indications, technical considerations, and potential complications, providing a vital resource for managing severe pain [3].
The integration of adjuvant analgesics is another cornerstone of multimodal cancer pain management. Non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, anticonvulsants, and antidepressants each possess unique mechanisms of action and evidence bases that support their use in specific cancer pain syndromes. Understanding these agents and their practical application is essential for comprehensive pain control [4].
Neuropathic cancer pain presents a distinct set of challenges, requiring careful differentiation from nociceptive pain. Specific pharmacologic and interventional approaches are tailored to address the complex mechanisms underlying neuropathic pain, highlighting the importance of accurate diagnosis and personalized treatment plans for this particularly distressing type of pain [5].
A palliative care approach is paramount in addressing the holistic needs of cancer patients experiencing pain. This involves not only effective symptom control but also crucial psychosocial support and clear communication. Early integration of palliative care services has been shown to significantly improve patient outcomes and overall quality of life [6].
Psychological interventions play a vital role in complementing pharmacologic and interventional therapies. Cognitive behavioral therapy, mindfulness, and hypnosis are among the techniques that empower patients to cope more effectively with pain, reduce associated anxiety and depression, and enhance their general well-being [7].
Pain arising from bone metastases is a common and profoundly debilitating symptom in advanced cancer. Effective management requires a combination of pharmacologic options, including bone-modifying agents, alongside radiation therapy and surgical interventions. The role of anesthesiology in providing relief for this specific type of pain is also a critical consideration [8].
Ethical considerations are central to end-of-life pain management for cancer patients. Issues surrounding informed consent, the principle of beneficence, and the judicious use of sedation require careful navigation. Upholding patient autonomy and ensuring comfort are the guiding principles in this sensitive domain [9].
Finally, regional anesthesia and interventional techniques are invaluable for managing cancer-related procedural and surgical pain. Methods such as peripheral nerve blocks, neuraxial blocks, and the use of intrathecal pumps are employed to provide targeted pain relief during and after various cancer treatments, further broadening the scope of anesthesiology in oncology [10].
Anesthesiologists are instrumental in the multidisciplinary management of cancer-related pain, employing pharmacologic strategies such as opioids and adjuvant analgesics, alongside interventional techniques like nerve blocks and neurolytic procedures. This comprehensive approach also addresses the psychological and existential dimensions of pain in cancer patients, underscoring the importance of early intervention to improve quality of life [1].
The optimal utilization of opioids in cancer pain management is a critical area of focus, addressing efficacy, potential side effects, and the risk of addiction. Comprehensive reviews cover current guidelines for opioid rotation, strategies for dose escalation, and effective management of common opioid-induced adverse effects like constipation and nausea, alongside approaches to managing breakthrough pain [2].
Interventional pain management techniques are explored for their efficacy in treating refractory cancer pain when pharmacologic methods are insufficient. Detailed descriptions of procedures such as epidural and intrathecal drug delivery, celiac plexus blocks, and superior hypogastric plexus blocks are provided, including their indications, technical aspects, and potential complications [3].
The integration of adjuvant analgesics into multimodal cancer pain management is a key component. The article outlines the mechanisms of action, evidence base, and practical considerations for using NSAIDs, corticosteroids, anticonvulsants, and antidepressants in managing specific pain syndromes associated with cancer [4].
Neuropathic cancer pain, distinct from nociceptive pain, requires specialized management strategies. The article differentiates these pain types and outlines specific pharmacologic and interventional approaches, emphasizing the critical need for accurate diagnosis and tailored treatment plans for this challenging condition [5].
The integration of a palliative care approach in cancer pain management is highlighted for its focus on symptom control, psychosocial support, and effective communication. Early involvement of palliative care is crucial for significantly improving patient outcomes and overall quality of life [6].
Psychological interventions are examined for their role in complementing other pain management modalities. Cognitive behavioral therapy, mindfulness, and hypnosis are discussed as effective methods for helping patients cope with pain, reduce anxiety and depression, and improve their overall well-being [7].
The management of pain associated with bone metastases, a common and debilitating cancer symptom, is reviewed. This includes pharmacologic options like bisphosphonates and denosumab, radiation therapy, surgical interventions, and the significant role of anesthesiology in providing relief [8].
Ethical considerations in end-of-life pain management for cancer patients are discussed, focusing on issues of consent, beneficence, and the appropriate use of sedation. The importance of respecting patient autonomy and prioritizing comfort is emphasized [9].
Regional anesthesia and interventional techniques are addressed for their application in managing cancer-related procedural and surgical pain. Techniques such as peripheral nerve blocks, neuraxial blocks, and intrathecal pumps are reviewed for their efficacy in managing pain during and after cancer treatments [10].
Cancer pain management is a complex area requiring a multidisciplinary approach, with anesthesiologists playing a key role. Strategies include pharmacologic interventions like opioids and adjuvant analgesics, as well as interventional techniques such as nerve blocks and drug delivery systems. The psychological and existential aspects of pain are also addressed, highlighting the importance of early intervention and palliative care. Managing specific pain types like neuropathic pain and pain from bone metastases requires tailored approaches. Ethical considerations are paramount, particularly in end-of-life care, focusing on patient autonomy and comfort. Regional anesthesia and interventional procedures offer targeted relief for procedural and surgical pain associated with cancer.
None
None
Journal of Anesthesiology and Pain Research received 835 citations as per Google Scholar report
